Molly Henderson
2020 - UroGen Pharma Ltd.
Compensation breakdown
Bonus | $100,000 |
---|---|
Non-Equity Incentive Plan | $69,875 |
Option Awards | $787,994 |
Salary | $94,269 |
Stock Awards | $294,900 |
Other | $15,192 |
Total | $1,362,230 |
Henderson received $788K in option awards, accounting for 58% of the total pay in 2020.
Henderson also received $100K in bonus, $69.9K in non-equity incentive plan, $94.3K in salary, $294.9K in stock awards and $15.2K in other compensation.
Rankings
In 2020, Molly Henderson's compensation ranked 7,273rd out of 13,090 executives tracked by ExecPay. In other words, Henderson earned more than 44.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,273 | 44th |
Manufacturing | 3,040 | 46th |
Chemicals And Allied Products | 1,226 | 46th |
Drugs | 1,059 | 46th |
Pharmaceutical Preparations | 792 | 46th |
Pay ratio
Molly Henderson's Pay | $1,362,230 |
---|---|
Median Employee's Pay | $222,109 |
Pay Ratio | 6to 1 |
In 2020, the annual total compensation of Molly Henderson was $1,362,230.
The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.
The ratio of Molly Henderson's pay to the pay of median employee was therefore 6 to one.
Henderson's colleagues
We found five more compensation records of executives who worked with Molly Henderson at UroGen Pharma Ltd. in 2020.
2020
Elizabeth Barrett
UroGen Pharma Ltd.
Chief Executive Officer
2020
Jason Smith
UroGen Pharma Ltd.
General Counsel
2020
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2020
Mark Schoenberg
UroGen Pharma Ltd.
Chief Medical Officer
2020
Stephen Mullennix
UroGen Pharma Ltd.
Chief Operating Officer
News
April 12, 2024
April 13, 2023
April 28, 2021
April 21, 2021